Discordant expression of LFA-1, VLA-4a, VKA-β1, CD45RO and CD28 on T-cell subsets : evidence for multiple subsets of memory T cellsKERN, F; DÖCKE, W. D; REINKE, P et al.International archives of allergy and immunology. 1994, Vol 104, Num 1, pp 17-26, issn 1018-2438Article

Quantitative determination of CD4/CD8 molecules by a cell marker ELISAFRANKE, L; NUGEL, E; DÖCKE, W.-D et al.Clinical chemistry (Baltimore, Md.). 1994, Vol 40, Num 1, pp 38-42, issn 0009-9147Article

Pentoxifylline promotes replication of human cytomegalovirus in vivo and in vitroSTAAK, K; PRÖSCH, S; STEIN, J et al.Blood. 1997, Vol 89, Num 10, pp 3682-3690, issn 0006-4971Article

Late acute rejection in renal allograft recipients is mediated by inflammatory rather than by cytotoxic T-cell-dependent mechanismsODE-HAKIM, S; DÖCKE, W.-D; MUTZE, S et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, pp 93-95, issn 0041-1345Conference Paper

Late acute rejection in long-term renal allograft recipients : diagnostic and predictive value of circulating activated T cellsREINKE, P; FIETZE, E; DÖCKE, W.-D et al.Transplantation. 1994, Vol 58, Num 1, pp 35-41, issn 0041-1337Article

Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitisDÖCKE, W.-D; KIESSLING, C; ASADULLAH, K et al.British journal of dermatology (1951). 2003, Vol 148, Num 5, pp 954-963, issn 0007-0963, 10 p.Article

Interleukin 10 treatment of psoriasis: Clinical results of a phase 2 trialASADULLAH, K; DÖCKE, W.-D; EBELING, M et al.Archives of dermatology (1960). 1999, Vol 135, Num 2, pp 187-192, issn 0003-987XArticle

Influence of monomethylfumarate on monocytic cytokine formation : explanation for adverse and therapeutic effects in psoriasis?ASADULLAH, K; SCHMID, H; FRIEDRICH, M et al.Archives of dermatological research (Print). 1997, Vol 289, Num 11, pp 623-630, issn 0340-3696Article

Impaired antigen presentation by human monocytes during endotoxin toleranceWOLK, K; DÖCKE, W.-D; VON BAEHR, V et al.Blood. 2000, Vol 96, Num 1, pp 218-223, issn 0006-4971Article

Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisationVON BAEHR, V; DÖCKE, W.-D; PLAUTH, M et al.Gut. 2000, Vol 47, Num 2, pp 281-287, issn 0017-5749Article

Interferon Gamma-1b in the treatment of compensatory anti-inflammatory response syndrome : A new approach : Proof of principleKOX, W. J; BONE, R. C; VOLK, H.-D et al.Archives of internal medicine (1960). 1997, Vol 157, Num 4, pp 389-393, issn 0003-9926Article

Verrucosis of hands and feet in a patient with combined immune deficiencyASADULLAH, K; RENZ, H; DÖCKE, W.-D et al.Journal of the American Academy of Dermatology. 1997, Vol 36, Num 5, pp 850-852, issn 0190-9622, 2Article

Monocyte deactivation : rationale for a new therapeutic strategy in sepsisVOLK, H.-D; REINKE, P; KRAUSCH, D et al.Intensive care medicine. Supplement. 1996, Vol 22, Num 4, pp S474-S481, issn 0935-1701Article

Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteersHARTUNG, T; DÖCKE, W.-D; GANTNER, F et al.Blood. 1995, Vol 85, Num 9, pp 2482-2489, issn 0006-4971Article

Cytokine expression in primary cutaneous germinal center cell lymphomasASADULLAH, K; GELLRICH, S; HAEUSSLER-QUADE, A et al.Experimental dermatology. 2000, Vol 9, Num 1, pp 71-76, issn 0906-6705Article

Interleukin-10 in der Dermatologie = Interleukin-10 in dermatologyASADULLAH, K; DÖCKE, W.-D; SABAT, R et al.Hautarzt. 1999, Vol 50, Num 1, pp 12-19, issn 0017-8470Article

A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis : an association with systemic tumour necrosis factor α overexpressionASADULLAH, K; PRÖSCH, S; AUDRING, H et al.British journal of dermatology (1951). 1999, Vol 141, Num 1, pp 94-102, issn 0007-0963Article

Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepressionWOICIECHOWSKY, C; SCHÖNING, B; LANKSCH, W. R et al.Journal of molecular medicine (Berlin. Print). 1999, Vol 77, Num 11, pp 769-780, issn 0946-2716Article

Delayed-type hypersensitivity-like mechanisms dominate late acute rejection episodes in renal allograft recipientsODE-HAKIM, S; DÖCKE, W.-D; KERN, F et al.Transplantation. 1996, Vol 61, Num 8, pp 1233-1240, issn 0041-1337Conference Paper

Monitoring of the cellular immune system in patients with biventricular assist devices awaiting cardiac transplantationHUMMEL, M; DÖCKE, W.-D; FRIEDEL, N et al.Clinical transplantation. 1994, Vol 8, Num 1, pp 59-66, issn 0902-0063Article

Flow cytometric characterization of lesional T cells in psoriasis : intracellular cytokine and surface antigen expression indicates an activated, memory/effector type 1 immunophenotypeFRIEDRICH, M; KRAMMIG, S; HENZE, M et al.Archives of dermatological research (Print). 2000, Vol 292, Num 10, pp 519-521, issn 0340-3696Article

Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypassHENSEL, M; VOLK, T; DÖCKE, W. D et al.Anesthesiology (Philadelphia). 1998, Vol 89, Num 1, pp 93-104, issn 0003-3022Article

Cytomegalovirus infection and common variable immunodeficiencyDÖCKE, W. D; SIMON, H. U; FIETZE, E et al.Lancet (British edition). 1991, Vol 338, Num 8782-3, issn 0140-6736, p. 1597Article

Cytomegalovirus reactivation and tumour necrosis factorDÖCKE, W. D; PRÖSCH, S; FIETZE, E et al.Lancet (British edition). 1994, Vol 343, Num 8892, pp 268-269, issn 0140-6736Article

Management of induction phase of immunosuppression in liver graft recipients : prevention of oversuppresion by immune monitoringSETTMACHER, U; DÖCKE, W. D; MANGER, T et al.Transplantation proceedings. 1993, Vol 25, Num 4, pp 2703-2704, issn 0041-1345Conference Paper